Literature DB >> 15711573

Toll-like receptor 3 promotes cross-priming to virus-infected cells.

Oliver Schulz1, Sandra S Diebold, Margaret Chen, Tanja I Näslund, Martijn A Nolte, Lena Alexopoulou, Yasu-Taka Azuma, Richard A Flavell, Peter Liljeström, Caetano Reis e Sousa.   

Abstract

Cross-presentation of cell-associated antigens plays an important role in regulating CD8+ T cell responses to proteins that are not expressed by antigen-presenting cells (APCs). Dendritic cells are the principal cross-presenting APCs in vivo and much progress has been made in elucidating the pathways that allow dendritic cells to capture and process cellular material. However, little is known about the signals that determine whether such presentation ultimately results in a cytotoxic T cell (CTL) response (cross-priming) or in CD8+ T cell inactivation (cross-tolerance). Here we describe a mechanism that promotes cross-priming during viral infections. We show that murine CD8alpha+ dendritic cells are activated by double-stranded (ds)RNA present in virally infected cells but absent from uninfected cells. Dendritic cell activation requires phagocytosis of infected material, followed by signalling through the dsRNA receptor, toll-like receptor 3 (TLR3). Immunization with virus-infected cells or cells containing synthetic dsRNA leads to a striking increase in CTL cross-priming against cell-associated antigens, which is largely dependent on TLR3 expression by antigen-presenting cells. Thus, TLR3 may have evolved to permit cross-priming of CTLs against viruses that do not directly infect dendritic cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15711573     DOI: 10.1038/nature03326

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  331 in total

1.  The toll-like receptor 3-mediated antiviral response is important for protection against poliovirus infection in poliovirus receptor transgenic mice.

Authors:  Yuko Abe; Ken Fujii; Noriyo Nagata; Osamu Takeuchi; Shizuo Akira; Hiroyuki Oshiumi; Misako Matsumoto; Tsukasa Seya; Satoshi Koike
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine.

Authors:  Maria L Knudsen; Alice Mbewe-Mvula; Maximillian Rosario; Daniel X Johansson; Maria Kakoulidou; Anne Bridgeman; Arturo Reyes-Sandoval; Alfredo Nicosia; Karl Ljungberg; Tomás Hanke; Peter Liljeström
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

3.  Control of solid tumor growth in mice using EGF receptor-targeted RNA replicase-based plasmid DNA.

Authors:  B Leticia Rodriguez; Xinran Li; Kaoru Kiguchi; John DiGiovanni; Evan C Unger; Zhengrong Cui
Journal:  Nanomedicine (Lond)       Date:  2012-02-02       Impact factor: 5.307

Review 4.  Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion.

Authors:  Søren Jensen; Allan Randrup Thomsen
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

5.  CD8+ T cell immunodominance in lymphocytic choriomeningitis virus infection is modified in the presence of toll-like receptor agonists.

Authors:  Sarah Siddiqui; Sameh Basta
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

Review 6.  Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination.

Authors:  Christophe J Desmet; Ken J Ishii
Journal:  Nat Rev Immunol       Date:  2012-06-22       Impact factor: 53.106

7.  A needle in the 'cancer vaccine' haystack.

Authors:  Anne Gallois; Nina Bhardwaj
Journal:  Nat Med       Date:  2010-08       Impact factor: 53.440

Review 8.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

9.  Marek's disease virus may interfere with T cell immunity by TLR3 signals.

Authors:  Xuming Hu; Wencai Xu; Aijian Qin; Genghua Wu; Kun Qian; Hongxia Shao; Jianqiang Ye
Journal:  Vet Res Commun       Date:  2014-03-02       Impact factor: 2.459

10.  Influenza virus and poly(I:C) inhibit MHC class I-restricted presentation of cell-associated antigens derived from infected dead cells captured by human dendritic cells.

Authors:  Davor Frleta; Chun I Yu; Eynav Klechevsky; Anne-Laure Flamar; Gerard Zurawski; Jacques Banchereau; A Karolina Palucka
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.